Influenzinum
Product Images NDC 0220-2651

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Influenzinum (NDC 0220-2651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laboratoires Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (12c)

Label for Influenzinum 12C homeopathic medicine by Laboratoires Boiron. The label includes the product name, potency 12C, NDC 0220-2651-41, and directions to take 5 pellets three times a day. It highlights warnings, inactive ingredients lactose and sucrose, and the product's use for after-effects of flu or flu-like symptoms. Manufacturer and contact information are also shown.*

FDA Label Image

Image (15c)

Label for Influenzinum 15c by Laboratoires Boiron. Includes Drug Facts about active ingredient, usage for flu symptoms, warnings, directions, and inactive ingredients lactose and sucrose. Displays NDC 0220-2651-41 with manufacturer contact and instructions to turn tube upside down to open.*

FDA Label Image

Image (200ck)

Label for Influenzinum 200 CK, a homeopathic medicine by Laboratoires Boiron. The label includes Drug Facts, warnings, directions for use of 5 pellets three times a day, and inactive ingredients lactose and sucrose. It advises to keep out of reach of children and includes contact information for Boiron in Newtown Square, PA, USA. The label references use for after-effects of flu or flu-like symptoms.*

FDA Label Image

Image (30c)

Packaging label for Influenzinum 30C by Laboratoires Boiron. The label includes dosage instructions of 5 pellets three times daily and mentions approximately 80 pellets per package. It also features warnings to stop use if symptoms persist beyond 3 days and precautions for pregnant or breastfeeding users. The label provides manufacturer contact information and includes basic inactive ingredient details such as lactose and sucrose.*

FDA Label Image

Image (30x)

Influenzinum pellet label from Laboratoires Boiron showing 30 pellets with NDC 0220-2651-41. The label includes drug facts, warnings, directions for use, and inactive ingredients lactose and sucrose. It also provides manufacturer contact information and instructions for opening the tube with a twist cap.*

FDA Label Image

Image (6c)

Label for Influenzinum 6C homeopathic pellets by Laboratoires Boiron shows the HPUS NDC 0220-2651-41. The label includes drug facts with active ingredient warnings, directions for use, and inactive ingredients lactose and sucrose. It states approx. 80 pellets per container and includes manufacturer contact details and usage instructions.*

FDA Label Image

Image (8x)

Packaging label for Influenzinum by Laboratoires Boiron showing the product name and NDC 0220-2651-41. The label includes directions and warnings in text form, indicating 5 pellets to be taken 3 times a day. The package size is shown as 8 doses. Instructions for opening the tube with a twist cap and turning it upside down are also visible.*

FDA Label Image

Image (9c Sd)

Influenzinum 9C homeopathic medicine label by Laboratoires Boiron. The label highlights the active ingredient as Influenzinum 9C and includes drug facts such as uses for after-effects of flu or flu-like symptoms, warnings, directions for use, and inactive ingredients. It also provides manufacturer and distributor information, storage instructions, and contact details. The product is made in France and distributed by Boiron Inc.*

FDA Label Image

Image (9c)

Label for Influenzinum 9C by Laboratoires Boiron showing the product name and homeopathic dilution strength. Includes Drug Facts with active ingredient and warnings, approximate pellet count, lot and expiration placeholders, and manufacturer contact details. Directions and inactive ingredients (lactose, sucrose) are noted along with usage indication for after-effects of flu or flu-like symptoms. Packaging instructions for tube opening are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.